“Take all that clubhouse [stuff] and all that, throw it out the window.
Every writer in the country has been writing about that [nonsense] for
years. Chemistry don’t mean [anything]. He’s up here because he’s good.
That don’t mean [a hill of beans]. They got good chemistry because their
team is improved, they got a real good team, they got guys knocking in
runs, they got a catcher hitting .336, they got a phenom pitcher they
just brought up. That’s why they’re happy.”
— Jim Leyland — whose every bracketed-phrase was likely an s-bomb — on the value of team chemistry.
From the “this does not surprise us in the very least” department, Tigers GM Al Avila announced today that the club is declining its $16 million option on right-hander Anibal Sanchez.
Sanchez had a terrible year in 2017, going 3-7 with a 6.41 ERA in 2017. That’s a long slide down from his 2013 season, in which he won the AL ERA title, going 14-8 and posting an ERA of 2.57 in the first year of his five-year, $80 million deal. Since then he’s gone 28-35 with a 5.15 ERA. He never started 30 games or more over the course of the contract.
The declination of the option does come with a nice parting gift for Sanchez: a $5 million buyout. Which is pretty dang high for a buyout, but that’s how the Tigers rolled three or four years ago.